TIGIT and gastric cancer: The exhaustion markers PDCD1, CTLA4, HAVCR2, LAG-3, and TIGIT were expressed at low levels in CD8+ T cells, which implied the benefit of immunotherapy would be limited for gastric cancer patients 16, 40.